InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by SULIMAN SHEHNAAZ, Director. Director active across 3 companies, notably Alector, Inc.. In total, 12 disclosures have been logged. The latest transaction was disclosed on 24 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
03,300 shares0
Common Stock
SEC:0001209191-22-039562:0·
02,120 shares0
Class A Common Stock
SEC:0001567619-22-013120:0·
€1m75,000 shares@ €15.25680.48% mcap79.1% of flow
Common Stock
SEC:0001209191-21-069643·
€1m75,000 shares@ €15.25680.48% mcap39.5% of flow
Common Stock
SEC:0001209191-21-069643:0·
€302,73419,813 shares@ €15.27960.13% mcap20.9% of flow
Common Stock
SEC:0001209191-21-069130·
€302,73419,813 shares@ €15.27960.13% mcap10.5% of flow
Common Stock
SEC:0001209191-21-069130:0·
02,145 shares0
Common Stock
SEC:0001209191-21-043535·
02,145 shares0
Common Stock
SEC:0001209191-21-043535:0·
0625 shares0
Class A Common Stock
SEC:0001209191-21-040697·
0625 shares0
Class A Common Stock
SEC:0001209191-21-040697:0·
0100,000 shares0
Common Stock
SEC:0001209191-21-031839·
0100,000 shares0
Common Stock
SEC:0001209191-21-031839:0·
12 of 12 declarations
About SULIMAN SHEHNAAZ
Shehnaaz Suliman is the CEO, Chairman of the Board, and Board Member at Alector, Inc., 10x Genomics, Inc., and Ultragenyx Pharmaceutical Inc. She is responsible for the strategic direction of these companies, ensuring alignment of operations with overall objectives. Her leadership and vision are essential in guiding these organizations through a competitive landscape.
